KRAS Mutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis.


Yenigun V. B., Acar H., Kanimdan E., Yenigün A., Kocyigit A., Cora T.

Anti-cancer agents in medicinal chemistry, 2023 (SCI-Expanded) identifier